A soak for relief: testing magnesium footbaths against menstrual cramps

NCT ID NCT07726264

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial investigates whether a 20-minute warm-water footbath containing magnesium sulfate can reduce pain in women with primary dysmenorrhea (painful periods). Around 120 women aged 18–35 are randomly assigned to receive the magnesium footbath, a plain warm-water footbath, or no intervention during the first three days of their period. Pain is measured before and up to two hours after the footbath using standard pain scales.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a warm-water footbath containing magnesium sulfate
What this could lead to
If it works, this could offer a simple, drug-free way to reduce period pain at home.
What could go wrong
This is a small, early-stage trial. The effect may be no better than a plain warm-water footbath, and results may not apply to all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Sep 2025

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 18-35 years * Having regular menstrual cycles * Experiencing primary dysmenorrhea * Having a menstrual pain score of at least 3 on the Visual Analogue Scale * Engaging in physical activity no more than twice per week * Having a body mass index of 29.9 kg/m² or lower * Willing to participate and providing informed consent Exclusion Criteria: * Previous childbirth * Presence of varicose veins, open wounds, or skin lesions on the feet or lower legs * Presence of an acute or chronic foot condition * Medical advice against warm-water footbath use * Use of hormonal contraceptives * Frequent use of anti-inflammatory or analgesic medications

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Primary dysmenorrhea are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kocaeli University

    Kocaeli, 41380, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.